NB
Neurocrine Biosciences
Every trial this sponsor leads in the registry, and everything it has published.
Recruiting13
Recruited2
By invitation1
Completed53
Stopped12
16 active · 20% of this sponsor’s registry footprint
Psychiatry & Addiction12 trials
Renal & Urology2 trials
Neurology1 trial
Not shown above: 1 trial whose condition matched no therapy area.
Trials by phase
Phase 121
Phase 234
Phase 322
Phase 44
Pipeline by phase · 6 drugs in active development
Phase 3 · 3 drugs
Phase 2 · 2 drugs
Phase 4 · 1 drug
Active trials only, code names and brands merged. 53 completed trials are in the counts above but their drugs are not folded into this pipeline.
Track your drug now for free
We check every one of its trials daily and tell you what moved.
- Status changeStatus moved to completedWas recruiting · always alerts
- Completion date movePrimary completion slipped 210 daysSlips and pull-ins of 30+ days
- New trialNew trial registered in your scopeFirst posted within 30 days
- Enrollment changeEnrollment grew to 1,200Moves of 15%+ or count finalised
- Substantive record editPrimary endpoint redefined from 24 to 52 weeksRead overnight and flagged in plain English
US registryClinicalTrials.gov
EU registryCTIS · Soon